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Background: The integration of new scientific discoveries into clinical practice costs
considerable time and resources. With the increased use of social media for scientific
communication, new opportunities arise to “bridge the gap” in translational medicine.
The present study aimed to investigate how medical professionals access scientific
information and understand their view on the role of social media in translational medicine.
Methods: A questionnaire regarding (i) the use of social media for scientific updates,
(ii) the opportunities and challenges of social media for translational medicine, (iii) social
media function Chatbot, and (iv) participant demographics was developed. The survey
link was posted online from February, 2018, until April, 2018.
Results: A total of 555 professionals responded to the survey. Respondents identified
themselves predominantly as researcher/scientists (27%) or medical/biomedical
students (15%). The majority of participants was employed at a university or research
institute (59%), and most practiced either in Europe (48%) or in Asia (37%). Seventy-eight
percent of respondents reported receiving most of scientific news and updates via
non-social media options, such as journal websites and newspapers. Fifty-one percent
of respondents believed that social media could contribute to closing the gap between
scientific discovery and translation to medical application. The most crucial opportunity
created by social media was found to be “connecting the right scientist to the right
clinician.” Participants rated “the translation of scientific finding to clinical practice is too
fast before the safety is properly demonstrated” as the most crucial challenge. Half of
the respondents were aware of their institutions policy on the professional use of social
media. Only 2% of respondents had previously used Chatbot.
Conclusions: Overall, medical professionals were positive about the idea that social
media could contribute to the progress of translational medicine. However, it is clear that
they are still being cautious about using social media for professional purposes. To fully
harness the potential of social media on translational medicine, the medical community
needs to be provided with educational programs, guidelines, and support infrastructure
within social media.
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INTRODUCTION
The integration of new scientific discoveries, whether they
be into clinical practice or into the pharmaceutical or
nutritional industries, costs considerable time and resources.
Most biomedical research institutions still excel in basic research.
However, less effort is given to the dissemination of information
to the general public. It is evident that a gap exists between the
biomedical research community and patients in need of their
discoveries (1). Although multiple organizations have dedicated
efforts to reduce the time to implement new knowledge and
research findings (2), the translation of progress made by basic,
preclinical researchers into new therapies that benefit patients
remains a long, difficult, and expensive process (3, 4).
Over the past decades, social media (SoMe) have aimed to
connect people from all over the world, with popular SoMe
forum Facebook’s mission statement even being “to bring the
world closer together” (5). The presence of medical journals on
social media, sharing of their articles, and appearance of multiple
entities that aim to explain the scientific findings to public could
give rise to a new opportunity to “bridge the gap” in translational
medicine. In addition to connecting medical professionals,
patients and other individuals can share scientific information on
SoMe as well, often adding their view on it. Moreover, large SoMe
forums such as Facebook, Twitter, Instagram, and LinkedIn allow
patients to organize themselves and raise both awareness and
funds for topics for which they share a common interest (6, 7).
SoMe also serve as a source of information for patients; thus, it
is crucial for the medical community to be aware and influence
the quality and assess the validity of the posted information
(8). The measures to evaluate the effect of the social media in
engagement of a population of interest are still being discussed
and developed. Generally, the number of likes is used as the most
frequent type of assessment of engagement (9); however, there
are some concerns with such approach. There is a possibility
that people like posts for various reasons and are not accessing
or reading the content. Thus, various new measures need to be
developed in order to improve the assessments of engagement by
social media.
Several studies have assessed the use of social media by
professionals. Mostly professionals use SoMe for personal rather
than professional purposes (10, 11). There are efforts to call
scientists into action to have a greater presence on SoMe as
professionals (12). However, there are also skeptics that warn
against potential pitfalls of social media (13, 14). Even though
SoMe platforms have been around for decades, the medical
society is late in embracing the use of them in a professional
setting. However, SoMe are here to stay! Thus, education about
the appropriate use of social media; implementation of policies
from government, institutions, and professional societies; and
full utilization of SoMe functions is crucial for bridging the
gap between scientific discovery and clinical applications and
involving the patients in all stages of translational research.
Introduction of these new platforms and applications that
could help to screen the information and interpret it could
Abbreviations: SoMe, social media.
benefit translation of research and support clinicians and
patients to find what they need in the enormous sea of facts
and news.
Automated conversational tools, or Chatbots, have begun to
receive interest in the healthcare and research spaces. Chatbots
often accompany SoMe, however, can function as independent
tools on any digital platform. A recent quick search on PubMed
for the term “Chatbots” revealed 31 publications, starting from as
early as 2011. While clearly a very new topic, the use of Chatbots
is picking up in both medical practice and research studies. Such
efforts are being made to create and use Chatbots in research and
in practice, particularly in the field of psychiatry, such as mental
health (15, 16); medication management (17); and behavioral
interventions in obesity (18). Pereira et al. (19) conducted a
search on the Chatbots in healthcare aiming at behavioral change.
The study revealed 30 articles mainly focusing on nutritional
and neurological disorders. Overall, there are multiple efforts to
create Chatbots to support patients and healthcare professionals.
However, there are no broadly used tools for this purpose.
Thus, in addition to the questions regarding SoMe, this study
aimed to create a better understanding about the awareness
of the medical and research professionals about Chatbots
and whether they have experience with this technology in
their practice.
In order for translational medicine professionals to utilize
social media to their best potential, it is necessary to better
understand how participants in this field, which include both
researchers and medical professionals, perceive and use SoMe
and their tools. Therefore, the aim of the present study was
to investigate how scientists and clinicians access scientific
information and provide insights into their view on the role of
social media in translational medicine.
METHODS
Survey Development
The survey was designed with the following research questions
in mind: “Do professionals use SoMe for scientific updates?,” “Do
professionals think that SoMe can contribute to the progress of
translational medicine?,” “How do professionals rate potential
opportunities and challenges that SoMe bring to translational
medicine?,” and “Do professionals use social media function
Chatbot?” In the development of the survey, the authors aimed
to include no more than 15 questions, so that it could be
completed in <5min and increase the likelihood of participation
in the survey. Questions on profession, workplace, age group
and geographic location were included in order to understand if
professionals’ attitude to SoMe is affected by any of these factors.
A total of 11 questions regarding participant demographics and
the research questions were developed based on consensus by
all authors. An overview of the survey questions is provided
in Table 1. The full survey including introductory text is
presented in the Supplementary Document 1. In adherence to
the guidelines of the SingHealth Centralized Institutional Review
Board (CIRB), the nature of this study met with the criteria to be
exempt from CIRB review.
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TABLE 1 | Questions and answer options of the survey.
Questions Dropdown selection/Answer options
1 What best describes your position/profession? a. Research assistant
b. Researcher/scientist
c. Professor
d. Medical professional
e. Clinician-scientist
f. Medical/Biomedical student
g. PhD student
h. Management position (in industry, institution)
i. Other (Please specify)
2 Where do you work/study? a. University or research institute
b. Academic hospital
c. Non-academic hospital
d. Industry (pharma, nutrition, medical device, etc.)
e. Other (Please specify)
3 What is your age range? a. Below 20
b. 20–30
c. 31–40
d. 41–50
e. Above 50
4 Where do you work? a. Europe
b. North America
c. South America
d. Africa
e. Asia
f. Australia
5 What sources do you use most to follow scientific news? (multiple
answers possible)
a. Journal’s websites
b. Newspapers and/or news applications on mobile devices
c. Update emails from journals
d. Updates from your institution (website, newsletters, etc.)
e. Facebook
f. Linkedin
g. Twitter
h. Other (Please specify)
6 Do you think that social media can contribute to closing the gap
between scientific discovery and its translation to medical application?
a. Yes
b. No
c. Maybe
7 If yes or maybe, which are the most crucial opportunities social media
create? (rate 1–6)
a. Faster dissemination of scientific information
b. Broader dissemination of scientific information
c. Allowing open criticism of scientific discoveries
d. Connecting the right scientist to the right clinician
e. Facilitating the recruitment in clinical studies
f. Facilitating surveys/online studies
g. Other (Please specify)
8 If yes or maybe, which are the most crucial challenges social media
create? (rate 1–4)
a. Distribution of fake news and incorrect conclusions
b. Distribution of fraud
c. Public over-reaction of un-confirmed findings
d. The translation of scientific finding to clinical practice is too fast before
the safety is properly demonstrated
e. Other (Please specify)
9 Are you familiar with chatbot (Robot human-like conversational tool
used on social media messaging platform)?
a. Never heard about it
b. Yes, I’ve heard about it but I’ve never used it
c. Yes, I use/have used this tool
10 Do you use chatbot (Robot human-like conversational tool used on
social media messaging platform) for your work?
a. Yes
b. No
11 Are you aware about your institutions policy on the professional use of
social media?
a. Yes
b. No
Survey Distribution
The survey was uploaded to online survey platform
SurveyMonkey using the ADVANTAGE Team plan and
was distributed via a number of forms of communication,
represented in Table 2 and Supplementary Document 2. In
addition, the link could have been shared by respondents via
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TABLE 2 | Survey distribution.
Sourcea Estimated number of
individuals reached
Singapore Women in Science 310
Eureka Institute alumni 241
Apollo Society chapters in Utrecht 30
Apollo Society chapters in Toronto 100
SingHealth 22,698
Institute of Medical Biology A*Star 300
Karolinska Institute facebook page 30,566
Utrecht University Medical students facebook
pages and website
1,800
Utrecht Institute for Pharmaceutical Sciences 58
Personal LinkedIn accounts, views 763
Personal Twitter accounts, views 27
Personal Facebook accounts, views 81
Emails to personal professional connections 494
Total 57,468
aThe survey was distributed to personal contacts, social media forums, and through
several scientific organizations. A brief description and the websites of these organizations
are provided in Supplementary Document 2.
their personal social networks and emails, which we would have
been unable to track. Thus, the total number of approached
professionals was estimated at 57,468.
The survey was launched on the 5th of February, 2018. The
survey results were downloaded on the 25th of April, 2018.
Data Analyses
Prior to survey conduct the margin error was set to be below
5% with 95% confidence interval. We estimated that the medical
and biomedical scientific community consists of 107 doctors
and 107 biomedical scientists (20). As the survey outcomes
are based on proportions and assuming the most conservative
standard deviation when the proportion is 50%, a minimum of
385 respondents would be required based on an online calculator
with a 5% margin of error (21, 22).
The analysis was performed using SurveyMonkey filtering
and comparing tools and Graphpad prism (version 6). The
number of respondents was converted into proportions and
these were then compared. Subgroup analyses were performed
for profession, workplace, age group and geographical location.
The total number of individuals in the group was set as 100
percent and the responses for the respective question were
compared. Bonferroni correction for multiple group comparison
was applied.
RESULTS
In the 11 weeks that the survey link was online, the total number
of respondents reached 555. As explained in the methods section,
a minimum of 385 respondents was calculated to lead to a margin
error<5%. The response rate in this study of 555 respondents led
to a margin error of 4.16% (22).
TABLE 3 | Respondents characteristics.
Characteristics N = 555
Profession, n (%)
Researcher/scientist 150 (27)
Medical/biomedical student 82 (15)
Medical professional 72 (13)
Professor 56 (10)
Management position 53 (10)
Clinician-scientist 43 (8)
Ph.D. student 38 (7)
Research assistant 27 (5)
Other 32 (6)
Participant skipped question 2 (0)
Workplace, n (%)
University or research institute 329 (59)
Academic hospital 111 (20)
Industry 68 (12)
Non-academic hospital 26 (5)
Other 21 (4)
Age group, n (%)
Below 20 8 (1)
20–30 161 (29)
31–40 192 (35)
41–50 130 (23)
Above 50 64 (12)
Geographical location, n (%)
Europe 268 (48)
Asia 203 (37)
North America 64 (12)
Australia 11 (2)
South America 7 (1)
Africa 0 (0)
Participant skipped question 2 (0)
Demographics of Survey Respondents
An overview of the demographic characteristics of the survey
respondents is provided in Table 3. Of those individuals
that participated in our study, the highest percentage
identified themselves as researcher/scientist (27%), followed by
medical/biomedical student (15%) and medical professional
(13%). The majority of participants were employed at a
university or research institute (59%). The age of survey
participants was grouped into several categories. The highest
proportion of participants were between the ages of 31–40 years
(35%), followed by 20–30 year olds (29%). While surveys were
distributed through contacts world-wide, most participants
indicated that they worked in either Europe (48%) or Asia (37%).
There were no respondents from Africa.
Sources of Scientific News
One of the possible functions of SoMe is information sharing. In
survey question 5, participants shared their use of SoMe vs. other
resources to update themselves on scientific news. A majority
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of participants (77.6%) reported receiving most of scientific
news and updates via non-social media options (Figure 1A). The
most utilized non-social media outlets included journal websites,
newspaper or news applications onmobile devices, update emails
from journals and updates or newsletters from the professional’s
individual institution. Of the 22.4% of respondents that used
social media as a means to receive scientific updates, participants
relied on Facebook, Linkedin, and Twitter.
Social Media in Closing the Gap Between
Scientific Discovery and Its Translation to
Medical Application
When asked if social media could contribute to closing the
gap between scientific discovery and translation to medical
application, half of the respondents (50.5%) said “yes,” while 41%
answered “maybe” and 8.5% answered “no” (Figure 1B). When
comparing these answers for subgroups, several differences were
found to be statistically significant (i.e., had a P-value < 0.05).
Based on profession, significantly more researchers/scientists
said “yes” then did professors, clinician-scientists and students.
Significantly more researchers/scientists indicated that they
believe SoMe can contribute to translational medicine
compared to those who said “no,” while significantly more
professors said “maybe” compared to those who said “yes”
(Supplementary Figure 1A). Lastly, significantly more students
said “no” compared to those who said “yes.” Answers differed
for age groups as well. The most optimistic age group was the
31–40 year olds, where significantly more respondents said “yes”
compared to those who said “no” (Supplementary Figure 1B).
No significant differences in responses to this question were
found between respondents working in different geographic
locations or types of workplaces (Supplementary Figure 1C and
data not shown).
Opportunities and Challenges of Social
Media in Translational Medicine
The respondents were asked to rate the most crucial
opportunities that SoMe create, with a rating of 1 indicating the
highest priority and 5 indicating the lowest priority. They scored
“connecting the right scientist to the right clinician” as the most
crucial with an average score of 2.85 (Figure 2A). “Facilitating
the recruitment in clinical studies,” “allowing open criticism of
scientific discoveries,” and “facilitating surveys/online studies”
scored 3.01, 3.1, and 3.2, respectively. The potential opportunities
found to be least crucial were “broader dissemination of scientific
information” and “faster dissemination of scientific information,”
scoring 4.71 and 4.8, respectively.
The respondents scored “the translation of scientific
finding to clinical practice is too fast before the safety is
properly demonstrated” and the “distribution of fraud”
as the most crucial challenges with average scores of 1.9
and 2.08, respectively (Figure 2B). “Public over-reaction of
unconfirmed findings” and “distribution of fake news and
incorrect conclusions” were believed to be less crucial at 2.95 and
3.34, respectively.
Institutional Policy on the Professional Use
of Social Media
Of the 555 participants, responses were split ∼50 and 50%
with those that were aware and those that were not aware
of their specific institutions policy on the professional use of
social media (Figure 3A). Those that were most aware were
clinician-scientists and respondents in management positions
(Figure 3B). Those that were the least aware were PhD
students and researcher/scientists. Overall, those employed by
industry or academic hospitals were more likely to be aware
of the institutions policy on SoMe usage compared to those
in non-academic hospitals and university/research institutes
(Figure 3C). There was a similar level of understanding (∼50:50)
among all age groups except in the under 20 group, which
was the smallest age group; in the under 20 group only 1
out of 8 respondents was aware of the social media policy of
their institution (Figure 3D).
Familiarity With and Usability of Chatbot
Participants were asked if they were familiar with Chatbot, a
robot-like conversational tool used on social media messaging
platforms. Chatbot is an example of functions within SoMe that
can be used by professionals to search for information. Of the
550 participants that answered this question, 45% responded
that they had “never heard about it (i.e., Chatbot);” while
43% answered “yes, I’ve heard of it but never used,” and only
17% responded “yes, I use/have used this tool.” Five hundred
and fifty-two of the participants responded to the question
“do you use Chatbot for your work?” A majority of 98%
of respondents answered “no” to this question (Figure 4 and
Supplementary Figure 2).
DISCUSSION
The last decade has completely re-shaped the way in which
we communicate. It has become clear that internet-based
communication is growing and all fields of life have to adapt
to its use, including the medical and research communities.
Communication on SoMe forms a large part of internet-based
communication and plays a crucial role in science information
sharing, discussion and implementation of scientific discoveries.
However, we are still learning how to properly use SoMe, while
also assessing the associated risks and benefits. In order to utilize
social media outlets to their best potential, while minimizing
their disadvantages, it is important to first understand how
social media are being perceived and utilized by members of the
translational medicine community.
The survey respondents in this study—predominantly
research scientists, medical professionals, and students—are
still relying on conventional non-social media methods, albeit
more often online, for reliable scientific news. Respondents
speculated that the gap between discovery and translation
could be bridged by SoMe, but at the same time feared that
premature dissemination of results might be unsafe. Moreover,
dissemination of fraud “fake” news was felt to be a problem.
Tools such as Chatbot, which may help professionals fish for
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FIGURE 1 | Social media in translational medicine. Use of social media for scientific updates (A). What sources do you use most to follow scientific news? Responses
to Question 5 of the survey are plotted in the bar graph. For the doughnut graph the responses were combined for all social media (Twitter, Facebook, and Linkedin)
and for non-social media sources (Journal’s websites, Newspapers and/or news applications on mobile devices, Update emails from journals, Updates from your
institution). Can social media contribute to closing the gap between scientific discovery and its translation to medical application (B)? Doughnut graph represents the
use of social media (Question 5) by those who responded YES to Question 6.
information on SoMe, seem to be utilized only minimally
amongst the survey respondents. This could be for several
reasons: there are still too few Chatbot tools that exist for
research and/or medical advice or professionals are less aware
about opportunities that Chatbot presents (23, 24).
In this study population, less than one-third of the medical
community utilized SoMe for scientific news. This may suggest
two things: (1) the medical community has not changed its
way of looking for reliable scientific information or (2) the
scientific journals have just started utilizing the power of SoMe
in transmitting scientific information to professionals. In this
study, specialized scientific social networking sites such as
ResearchGate and Mendeley were not included in the popular
list. However, among the answer “others,” only a few participants
listed ResearchGate, Medscape, and Google Scholar.
Despite the smaller proportion of the scientific community
relying on scientific news in SoMe more than half indicated that
they “believed” that it has the potential to close the gap between
scientific discovery and its translation to medical application.
This may suggest that the society is in a transition phase between
starting to explore the functions of SoMe and fully utilizing
them professionally. Interestingly, the number of students in the
survey that were optimistic in their belief that SoMe could close
the gap between scientific discovery and translation to medical
application was relatively small compared to researchers. We
could not explain this phenomenon due to the small sample size
and lack of additional data. If this finding is indeed true, it may be
necessary to familiarize the student community with social media
tools in translational aspects of medicine and consider adapting
our education programs to include the use of SoMe training.
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FIGURE 2 | Opportunities and challenges of social media in translational medicine. The most crucial opportunities social media create (A) (Q7) [If you answered yes or
maybe to the previous question, which are the most crucial opportunities social media create (rate with 1 being the highest)]. The most crucial challenges social media
create (B) (Q8) [If you answered yes or maybe to question 6, which are the most crucial challenges social media create (rate with 1 being the highest)]. Average score
from all the respondents for each statement have been calculated and presented in the bar graph.
The favorite opportunity that the majority researcher/scientist
respondents sought for social media to address was “to connect
clinician and scientist,” which is an important step in translational
research. It may also be a challenge with only 8% clinician
scientists responding in this survey. This can be noted by policy
makers in bridging the communities through better usage of
SoMe platforms within institutes, across scientific communities,
and the public. Embracing SoMe in disseminating knowledge and
research in public health seems to be adopted by many scientific
(9, 25, 26) and patient forums already (27). Dissemination of
internal policies to the students and researchers seems a priority
in this respect, as they were least aware of the SoMe usage rules
within their institutes.
There are tools available for professionals to utilize for
“recruitment and clinical trials,” such as Chatbots (12) and text
mining approaches (28). However, the actual usage seems to be
poor. While adaptation to such tools may be considered, caution
should be exercised as these can also be subjected to trolling,
privacy and other ethical issues (29). Any workshop or awareness
program in this respect should engage ethical and technical
experts to caution the “tech-naïve” medical professionals. It is no
surprise that the “broader and faster dissemination of scientific
knowledge” component of SoMe seems to be less appealing
to a medical community. However, with more time spent on
SoMe by the current and future generation, it may only be
prudent for the scientific community to tap on this opportunity
to disseminate new scientific information through SoMe in a
reliable and realistic manner.
“Distribution of early clinical trials to patient community and
false information” is undoubtedly the biggest challenge aspect
surfacing in this survey, and it will prove to be a challenge
that need to be tackled by the medical community in future
(2, 13, 30). In this context, an active participation of the journals
in disseminating such information, especially after subjecting
the content to peer review before publication, may alleviate
such issues.
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FIGURE 3 | Awareness about own institution’s policy on use of social media. The responses to Question 11, “Are you aware about your institutions policy on the
professional use of social media?” are shown on the column graph in percentages (A). Institutions policy and occupation (B). Institutions policy and workplace (C).
Institutions policy and age (D). The bar graph illustrates the percent of each occupation/workplace/age group of the respondents that answered with NO (olive bar) and
YES (light orange bar) to Question 11. The numbers at each side of the bar indicate the number of responses for NO/YES for each occupation/workplace/age group.
FIGURE 4 | Awareness and use of Chatbot. Are you familiar with Chatbot (A)? Do you use Chatbot for your work (B)? Responses to Question 10 were plotted on the
column graph in percentages.
The growth of platforms for interactions of professionals,
such as Labspaces, Sermo, DailyRounds, Among Doctors, and
others might be beneficial for the purpose of interaction
of within professional groups (31). However, they do not
integrate other professions or members of the public.
Another approach would be to create pages or groups
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within bigger social media portals, mainly Twitter and
Facebook (12, 32).
In the present survey study, the focus of the analysis was on
the whole community of medical professionals and researchers.
Some of the occupations might be under-represented, such
as PhD students, clinician-scientists and research assistants
(Table 3). Future studies should focus on these groups specifically
to understand the use of SoMe. The present study was also
limited by its low representation of professionals working in
Africa and South America. It would be interesting to conduct a
survey focusing on Africa in particular, as this is the continent
with lowest internet and SoMe penetration, whereas North and
South America have comparable internet and SoMe use (33, 34).
The growing use of social media in Africa is an opportunity
for dissemination of truthful information and engagement
of the African community. Groups from trusted universities
have the capacity of engaging new readers. Online educational
programs for the use of social media would also be able to
reach a bigger audience. Moreover, in this survey study, we
focused on scientists and medical professionals. Clearly, there
are other professions that contribute to translational medicine
such as clinical study specialists, statisticians and data managers,
patent attorneys, legal professionals who work with research
and development, hospital and institutional administration,
science communicators, patients, venture capitalists, and others.
In order to complete the picture, future studies would need
to assess the holistic relationship of all the people involved
in the path of science creation and translation to medical
applications, which will also include the end users’ (i.e.,
patients) inputs.
The current study also puts social media to the test in
conducting the actual research presented in this study. Only a
small fraction of people whom the survey could potentially reach
chose to participate (555 out of 57,468). Thus, future strategies
for dissemination of such research which utilizes SoMe as the
only outlet needs to consider the limitations for this method for
dissemination. While common methods to bolster engagement
include paid advertisement of the surveys, attracting influencers
with significant followers and other innovative solutions, one
must take into account that certain countries and age groups
may not respond to such surveys on SoMe for a wide variety of
unknown and unpredictable reasons.
Our study highlights that there is a clear need for specific
educational programs and guidelines to be provided to the
medical community in order for participants to harness the
potential of SoMe on advancing discoveries and treatments in
translational medicine. Such programs could include courses
in universities dedicated to SoMe opportunities, pitfalls, and
use. There should be courses with continual medical education
(CME) credit points for educating the current workforce. In
addition, SoMe could also be utilized for education purposes
via scientific journals or university groups. Finally, encouraging
more research in this area would also improve our understanding
and help to grow the capable community to utilize SoMe to the
full potential.
In conclusion, we found that the overall awareness of social
media’s role in translational medicine was realized by the medical
community in this survey, but there seems to be lack of practical
applications and utility. Educational programs and guidelines
may provide the medical community with the tools to harness
its potential.
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